Review



cck8 reagent keygen  (Keygen Biotech)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Keygen Biotech cck8 reagent keygen
    PDCD1 knockdown alters proliferation, invasion, and migration in MCF7. a qPCR validation of PDCD1 knockdown efficiency following siRNA transfection in MCF7. b <t>CCK8</t> assay demonstrating a significant reduction in cell proliferation following PDCD1 knockdown compared to the control group. c Transwell assay results showing a marked decrease in the invasive capacity ofMCF7 upon PDCD1 knockdown relative to the control group. d Wound healing assay illustrating a notable reduction in wound closure ability in PDCD1 knockdown cells compared to the control group. e EDU assay displaying a significant decrease in fluorescence intensity following PDCD1 knockdown, indicating reduced cell proliferation. * p < 0.001 for all comparisons, *** p < 0.0001.
    Cck8 Reagent Keygen, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cck8 reagent keygen/product/Keygen Biotech
    Average 90 stars, based on 1 article reviews
    cck8 reagent keygen - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Novel multi-omics analysis revealing metabolic heterogeneity of breast cancer cell and subsequent development of associated prognostic signature"

    Article Title: Novel multi-omics analysis revealing metabolic heterogeneity of breast cancer cell and subsequent development of associated prognostic signature

    Journal: Translational Oncology

    doi: 10.1016/j.tranon.2025.102444

    PDCD1 knockdown alters proliferation, invasion, and migration in MCF7. a qPCR validation of PDCD1 knockdown efficiency following siRNA transfection in MCF7. b CCK8 assay demonstrating a significant reduction in cell proliferation following PDCD1 knockdown compared to the control group. c Transwell assay results showing a marked decrease in the invasive capacity ofMCF7 upon PDCD1 knockdown relative to the control group. d Wound healing assay illustrating a notable reduction in wound closure ability in PDCD1 knockdown cells compared to the control group. e EDU assay displaying a significant decrease in fluorescence intensity following PDCD1 knockdown, indicating reduced cell proliferation. * p < 0.001 for all comparisons, *** p < 0.0001.
    Figure Legend Snippet: PDCD1 knockdown alters proliferation, invasion, and migration in MCF7. a qPCR validation of PDCD1 knockdown efficiency following siRNA transfection in MCF7. b CCK8 assay demonstrating a significant reduction in cell proliferation following PDCD1 knockdown compared to the control group. c Transwell assay results showing a marked decrease in the invasive capacity ofMCF7 upon PDCD1 knockdown relative to the control group. d Wound healing assay illustrating a notable reduction in wound closure ability in PDCD1 knockdown cells compared to the control group. e EDU assay displaying a significant decrease in fluorescence intensity following PDCD1 knockdown, indicating reduced cell proliferation. * p < 0.001 for all comparisons, *** p < 0.0001.

    Techniques Used: Knockdown, Migration, Biomarker Discovery, Transfection, CCK-8 Assay, Control, Transwell Assay, Wound Healing Assay, EdU Assay, Fluorescence



    Similar Products

    cck8 reagent keygen  (Keygen Biotech)
    90
    Keygen Biotech cck8 reagent keygen
    PDCD1 knockdown alters proliferation, invasion, and migration in MCF7. a qPCR validation of PDCD1 knockdown efficiency following siRNA transfection in MCF7. b <t>CCK8</t> assay demonstrating a significant reduction in cell proliferation following PDCD1 knockdown compared to the control group. c Transwell assay results showing a marked decrease in the invasive capacity ofMCF7 upon PDCD1 knockdown relative to the control group. d Wound healing assay illustrating a notable reduction in wound closure ability in PDCD1 knockdown cells compared to the control group. e EDU assay displaying a significant decrease in fluorescence intensity following PDCD1 knockdown, indicating reduced cell proliferation. * p < 0.001 for all comparisons, *** p < 0.0001.
    Cck8 Reagent Keygen, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cck8 reagent keygen/product/Keygen Biotech
    Average 90 stars, based on 1 article reviews
    cck8 reagent keygen - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cck8 reagent keygen biotech  (Keygen Biotech)
    90
    Keygen Biotech cck8 reagent keygen biotech
    PDCD1 knockdown alters proliferation, invasion, and migration in MCF7. a qPCR validation of PDCD1 knockdown efficiency following siRNA transfection in MCF7. b <t>CCK8</t> assay demonstrating a significant reduction in cell proliferation following PDCD1 knockdown compared to the control group. c Transwell assay results showing a marked decrease in the invasive capacity ofMCF7 upon PDCD1 knockdown relative to the control group. d Wound healing assay illustrating a notable reduction in wound closure ability in PDCD1 knockdown cells compared to the control group. e EDU assay displaying a significant decrease in fluorescence intensity following PDCD1 knockdown, indicating reduced cell proliferation. * p < 0.001 for all comparisons, *** p < 0.0001.
    Cck8 Reagent Keygen Biotech, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cck8 reagent keygen biotech/product/Keygen Biotech
    Average 90 stars, based on 1 article reviews
    cck8 reagent keygen biotech - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cck8 reagent (keygen, china)  (Keygen Biotech)
    90
    Keygen Biotech cck8 reagent (keygen, china)
    PDCD1 knockdown alters proliferation, invasion, and migration in MCF7. a qPCR validation of PDCD1 knockdown efficiency following siRNA transfection in MCF7. b <t>CCK8</t> assay demonstrating a significant reduction in cell proliferation following PDCD1 knockdown compared to the control group. c Transwell assay results showing a marked decrease in the invasive capacity ofMCF7 upon PDCD1 knockdown relative to the control group. d Wound healing assay illustrating a notable reduction in wound closure ability in PDCD1 knockdown cells compared to the control group. e EDU assay displaying a significant decrease in fluorescence intensity following PDCD1 knockdown, indicating reduced cell proliferation. * p < 0.001 for all comparisons, *** p < 0.0001.
    Cck8 Reagent (Keygen, China), supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cck8 reagent (keygen, china)/product/Keygen Biotech
    Average 90 stars, based on 1 article reviews
    cck8 reagent (keygen, china) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    cck8 solution reagent keygen biotech  (Keygen Biotech)
    90
    Keygen Biotech cck8 solution reagent keygen biotech
    PDCD1 knockdown alters proliferation, invasion, and migration in MCF7. a qPCR validation of PDCD1 knockdown efficiency following siRNA transfection in MCF7. b <t>CCK8</t> assay demonstrating a significant reduction in cell proliferation following PDCD1 knockdown compared to the control group. c Transwell assay results showing a marked decrease in the invasive capacity ofMCF7 upon PDCD1 knockdown relative to the control group. d Wound healing assay illustrating a notable reduction in wound closure ability in PDCD1 knockdown cells compared to the control group. e EDU assay displaying a significant decrease in fluorescence intensity following PDCD1 knockdown, indicating reduced cell proliferation. * p < 0.001 for all comparisons, *** p < 0.0001.
    Cck8 Solution Reagent Keygen Biotech, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cck8 solution reagent keygen biotech/product/Keygen Biotech
    Average 90 stars, based on 1 article reviews
    cck8 solution reagent keygen biotech - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    PDCD1 knockdown alters proliferation, invasion, and migration in MCF7. a qPCR validation of PDCD1 knockdown efficiency following siRNA transfection in MCF7. b CCK8 assay demonstrating a significant reduction in cell proliferation following PDCD1 knockdown compared to the control group. c Transwell assay results showing a marked decrease in the invasive capacity ofMCF7 upon PDCD1 knockdown relative to the control group. d Wound healing assay illustrating a notable reduction in wound closure ability in PDCD1 knockdown cells compared to the control group. e EDU assay displaying a significant decrease in fluorescence intensity following PDCD1 knockdown, indicating reduced cell proliferation. * p < 0.001 for all comparisons, *** p < 0.0001.

    Journal: Translational Oncology

    Article Title: Novel multi-omics analysis revealing metabolic heterogeneity of breast cancer cell and subsequent development of associated prognostic signature

    doi: 10.1016/j.tranon.2025.102444

    Figure Lengend Snippet: PDCD1 knockdown alters proliferation, invasion, and migration in MCF7. a qPCR validation of PDCD1 knockdown efficiency following siRNA transfection in MCF7. b CCK8 assay demonstrating a significant reduction in cell proliferation following PDCD1 knockdown compared to the control group. c Transwell assay results showing a marked decrease in the invasive capacity ofMCF7 upon PDCD1 knockdown relative to the control group. d Wound healing assay illustrating a notable reduction in wound closure ability in PDCD1 knockdown cells compared to the control group. e EDU assay displaying a significant decrease in fluorescence intensity following PDCD1 knockdown, indicating reduced cell proliferation. * p < 0.001 for all comparisons, *** p < 0.0001.

    Article Snippet: To ensure experimental reproducibility, three replicate wells were prepared for each experimental group.According to the manufacturer's instructions, CCK8 reagent (KeyGEN, China) was combined with complete culture medium to ensure a total volume of 200 μl per well, which was rapidly added to the 96-well plate using a pipette.

    Techniques: Knockdown, Migration, Biomarker Discovery, Transfection, CCK-8 Assay, Control, Transwell Assay, Wound Healing Assay, EdU Assay, Fluorescence